Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap
Farnaz Daneshnia, João Nóbrega de Almeida, Macit İlkit, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 6, pp. e470-e480
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Invasive candidiasis
Cornelia Lass‐Flörl, Souha S. Kanj, Nelesh P. Govender, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 59
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
George R. Thompson, Jeffrey D. Jenks, John W. Baddley, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 3
Open Access | Times Cited: 42
The WHO fungal priority pathogens list: a crucial reappraisal to review the prioritisation
Giacomo Casalini, Andrea Giacomelli, Spinello Antinori
The Lancet Microbe (2024) Vol. 5, Iss. 7, pp. 717-724
Open Access | Times Cited: 32
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 32
Social determinants of health as drivers of fungal disease
Jeffrey D. Jenks, Juergen Prattes, Sebastian Wurster, et al.
EClinicalMedicine (2023) Vol. 66, pp. 102325-102325
Open Access | Times Cited: 27
Attributable mortality of candidemia – Results from the ECMM Candida III multinational European Observational Cohort Study
Jon Salmanton‐García, Oliver A. Cornely, Jannik Stemler, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106229-106229
Open Access | Times Cited: 14
Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections
Bing Zhai, Chen Liao, Siddharth Jaggavarapu, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3163-3172
Closed Access | Times Cited: 14
Epidemiology of Invasive Candidiasis
Derek J. Bays, Emily N Jenkins, Meghan Lyman, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 549-566
Open Access | Times Cited: 10
Universal digital high-resolution melting for the detection of pulmonary mold infections
Tyler Goshia, April Aralar, Nathan P. Wiederhold, et al.
Journal of Clinical Microbiology (2024) Vol. 62, Iss. 6
Open Access | Times Cited: 9
Evaluation of outbreak persistence caused by multidrug-resistant and echinocandin-resistant Candida parapsilosis using multidimensional experimental and epidemiological approaches
Farnaz Daneshnia, Daniel Floyd, Adam P. Ryan, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Global Burden of Fungal Infections and Antifungal Resistance from 1961 to 2024: Findings and Future Implications
Steward Mudenda
Pharmacology & Pharmacy (2024) Vol. 15, Iss. 04, pp. 81-112
Open Access | Times Cited: 8
Molecular and Epidemiological Investigation of Fluconazole-resistant Candida parapsilosis—Georgia, United States, 2021
Elizabeth Misas, Lucy S Witt, Monica M. Farley, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 8
Rapid Identification of Clinically Relevant Candida spp. by I-dOne Software Using Attenuated Total Reflectance Fourier Transform Infrared (ATR-FTIR) Spectroscopy
Iacopo Franconi, Roberta Fais, Cesira Giordano, et al.
Journal of Fungi (2025) Vol. 11, Iss. 1, pp. 40-40
Open Access | Times Cited: 1
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study
Antonio Vena, Giusy Tiseo, Marco Falcone, et al.
Clinical Infectious Diseases (2025)
Closed Access | Times Cited: 1
Optimizing the Treatment of Invasive Candidiasis—A Case for Combination Therapy
Rachel Wake, Phoebe E Allebone-Salt, Larissa L.H. John, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 6
Open Access | Times Cited: 7
Increase in candidemia cases and emergence of fluconazole-resistant Candida parapsilosis and C. auris isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023
Maria Siopi, Panagiota-Christina Georgiou, Paschalis Paranos, et al.
Eurosurveillance (2024) Vol. 29, Iss. 29
Open Access | Times Cited: 7
Fluconazole‐resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole‐resistance profiles associated with the Y132F ERG11p substitution
Aína Mesquida, Eva Alcoceba, Eduardo Padilla, et al.
Mycoses (2024) Vol. 67, Iss. 3
Closed Access | Times Cited: 6
Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies and management challenges
Maddalena Giannella, Fanny Lanternier, Sarah Dellière, et al.
Clinical Microbiology and Infection (2024)
Closed Access | Times Cited: 6
Candida parapsilosis Sensu Stricto Antifungal Resistance Mechanisms and Associated Epidemiology
Iacopo Franconi, Cosmeri Rizzato, Noemi Poma, et al.
Journal of Fungi (2023) Vol. 9, Iss. 8, pp. 798-798
Open Access | Times Cited: 14
Precise genome editing underlines the distinct contributions of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes to antifungal resistance in Candida parapsilosis
Sophie Hartuis, Isabelle Ourliac‐Garnier, Estelle Robert, et al.
Antimicrobial Agents and Chemotherapy (2024)
Closed Access | Times Cited: 5
Short Tandem Repeat Genotyping of Medically Important Fungi: A Comprehensive Review of a Powerful Tool with Extensive Future Potential
Bram Spruijtenburg, Jacques F. Meis, Paul E. Verweij, et al.
Mycopathologia (2024) Vol. 189, Iss. 5
Open Access | Times Cited: 5
Diagnosing fungal infections in clinical practice: a narrative review
Sarah Sedik, Stella Wolfgruber, Martin Hoenigl, et al.
Expert Review of Anti-infective Therapy (2024)
Closed Access | Times Cited: 5
Anti-fungal effects of novel N-(tert-butyl)-2-(pyridin-2-yl)imidazo[1,2-a]pyridin-3-amine derivative and it’s in-vitro, in-silico, and mode of action against Candida spp.
Manivannan Nandhagopal, Ramanjaneyulu Mala, Kanagasabai Somarathinam, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 4
Closed Access | Times Cited: 4
Approaches for identifying and measuring heteroresistance in azole-susceptible Candida isolates
Cécile Gautier, Eli Isael Maciel, Iuliana V. Ene
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 4
Genotypic and phenotypic characteristics of Candida parapsilosis bloodstream isolates: Health Care Associated Infections in a teaching Hospital in Italy
Giuseppina Caggiano, Simona Fioriti, Gianluca Morroni, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 6, pp. 967-974
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top